{
    "eid": "2-s2.0-85048749584",
    "title": "Clinical and Dosimetric Factors Predicting Grade \u22652 Radiation Pneumonitis After Postoperative Radiotherapy for Patients With Non-Small Cell Lung Carcinoma",
    "cover-date": "2018-07-15",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Radiation",
            "@code": "3108",
            "@abbrev": "PHYS"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Radiology, Nuclear Medicine and Imaging",
            "@code": "2741",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [],
    "authors": [
        "Keeratikarn Boonyawan",
        "Daniel R. Gomez",
        "Ritsuko Komaki",
        "Yujin Xu",
        "Chonnipa Nantavithya",
        "Pamela K. Allen",
        "Radhe Mohan",
        "Zhongxing Liao"
    ],
    "citedby-count": 29,
    "ref-count": 22,
    "ref-list": [
        "Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database",
        "Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: The adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial",
        "Impact of adjuvant treatment for microscopic residual disease after non-small cell lung cancer surgery",
        "Potential clinical predictors of outcome after postoperative radiotherapy of non-small cell lung cancer",
        "Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer",
        "Risk factors of pneumonitis following chemoradiotherapy for lung cancer",
        "Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer",
        "Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer",
        "Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients",
        "Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)",
        "Non-small cell lung cancer",
        "Predictive factors for acute radiation pneumonitis in postoperative intensity modulated radiation therapy and volumetric modulated arc therapy of esophageal cancer",
        "Common Terminology Criteria for Adverse Events (CTCAE) version 4.03, June 2010",
        "A proportional hazards model for the subdistribution of a competing risk",
        "Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: An international individual patient data meta-analysis",
        "Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer",
        "Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy",
        "Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates",
        "Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer",
        "Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: A secondary analysis of the NRG Oncology RTOG 0617 randomized clinical trial",
        "Fatal pneumonitis associated with postoperative intensity-modulated radiotherapy in lung cancer: Case report and review",
        "124P: Acute severe radiation pneumonitis in post-operation radiation therapy among patients with lung cancer: An analysis of dose-volume parameters"
    ],
    "affiliation": [
        {
            "affiliation-city": "Houston",
            "@id": "60015023",
            "affilname": "The University of Texas MD Anderson Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015023",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hangzhou",
            "@id": "60073540",
            "affilname": "Zhejiang Cancer Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073540",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "National Cancer Institute",
        "National Institutes of Health",
        "Anderson Cancer Center"
    ]
}